Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility are currrently unavailable.

Marianna Halasi, Ph.D.


Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Chesnokov MS, Borhani S, Halasi M, Arbieva Z, Khan I, Gartel AL. FOXM1-AKT Positive Regulation Loop Provides Venetoclax Resistance in AML. Front Oncol. 2021; 11:696532. PMID: 34381718.
  2. Chesnokov MS, Halasi M, Borhani S, Arbieva Z, Shah BN, Oerlemans R, Khan I, Camacho CJ, Gartel AL. Novel FOXM1 inhibitor identified via gene network analysis induces autophagic FOXM1 degradation to overcome chemoresistance of human cancer cells. Cell Death Dis. 2021 07 14; 12(7):704. PMID: 34262016.
    Citations:    Fields:    Translation:HumansCells
  3. Freilikhman S, Halasi M, Eran A, Adini I. Melanocytes determine angiogenesis gene expression across human tissues. PLoS One. 2021; 16(5):e0251121. PMID: 33983985.
    Citations:    Fields:    
  4. Khan I, Halasi M, Patel A, Schultz R, Kalakota N, Chen YH, Aardsma N, Liu L, Crispino JD, Mahmud N, Frankfurt O, Gartel AL. FOXM1 contributes to treatment failure in acute myeloid leukemia. JCI Insight. 2018 08 09; 3(15). PMID: 30089730.
    Citations: 4     Fields:    Translation:HumansAnimalsCells
  5. Halasi M, Hitchinson B, Shah BN, Váraljai R, Khan I, Benevolenskaya EV, Gaponenko V, Arbiser JL, Gartel AL. Honokiol is a FOXM1 antagonist. Cell Death Dis. 2018 01 24; 9(2):84. PMID: 29367668.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  6. Khan I, Halasi M, Zia MF, Gann P, Gaitonde S, Mahmud N, Gartel AL. Nuclear FOXM1 drives chemoresistance in AML. Leukemia. 2017 01; 31(1):251-255. PMID: 27694928.
    Citations: 11     Fields:    Translation:HumansCells
  7. Halasi M, Váraljai R, Benevolenskaya E, Gartel AL. A Novel Function of Molecular Chaperone HSP70: SUPPRESSION OF ONCOGENIC FOXM1 AFTER PROTEOTOXIC STRESS. J Biol Chem. 2016 Jan 01; 291(1):142-8. PMID: 26559972.
    Citations: 13     Fields:    Translation:HumansCells
  8. Halasi M, Pandit B, Gartel AL. Proteasome inhibitors suppress the protein expression of mutant p53. . 2014; 13(20):3202-6. PMID: 25485499.
    Citations: 8     Translation:HumansCells
  9. Halasi M, Wang M, Chavan TS, Gaponenko V, Hay N, Gartel AL. ROS inhibitor N-acetyl-L-cysteine antagonizes the activity of proteasome inhibitors. Biochem J. 2013 Sep 01; 454(2):201-8. PMID: 23772801.
    Citations: 73     Fields:    Translation:HumansCells
  10. Halasi M, Pandit B, Wang M, Nogueira V, Hay N, Gartel AL. Combination of oxidative stress and FOXM1 inhibitors induces apoptosis in cancer cells and inhibits xenograft tumor growth. Am J Pathol. 2013 Jul; 183(1):257-65. PMID: 23665201.
    Citations: 14     Fields:    Translation:HumansAnimalsCells
  11. Halasi M, Gartel AL. FOX(M1) news--it is cancer. Mol Cancer Ther. 2013 Mar; 12(3):245-54. PMID: 23443798.
    Citations: 93     Fields:    Translation:Humans
  12. Halasi M, Gartel AL. Targeting FOXM1 in cancer. Biochem Pharmacol. 2013 Mar 01; 85(5):644-652. PMID: 23103567.
    Citations: 67     Fields:    Translation:Humans
  13. Wang M, Halasi M, Kabirov K, Banerjee A, Landolfi J, Lyubimov AV, Gartel AL. Combination treatment with bortezomib and thiostrepton is effective against tumor formation in mouse models of DEN/PB-induced liver carcinogenesis. Cell Cycle. 2012 Sep 15; 11(18):3370-2. PMID: 22894930.
    Citations: 4     Fields:    Translation:Animals
  14. Halasi M, Gartel AL. Suppression of FOXM1 sensitizes human cancer cells to cell death induced by DNA-damage. PLoS One. 2012; 7(2):e31761. PMID: 22393369.
    Citations: 35     Fields:    Translation:HumansCells
  15. Bhat UG, Jagadeeswaran R, Halasi M, Gartel AL. Nucleophosmin interacts with FOXM1 and modulates the level and localization of FOXM1 in human cancer cells. J Biol Chem. 2011 Dec 02; 286(48):41425-41433. PMID: 21979956.
    Citations: 24     Fields:    Translation:HumansAnimalsCells
  16. Halasi M, Zhao H, Dahari H, Bhat UG, Gonzalez EB, Lyubimo AV, Tonetti DA, Gartel AL. Thiazole antibiotics against breast cancer. Cell Cycle. 2010 Mar 15; 9(6):1214-7. PMID: 20410687.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  17. Pandit B, Halasi M, Gartel AL. p53 negatively regulates expression of FoxM1. . 2009 Oct 15; 8(20):3425-7. PMID: 19806025.
    Citations: 52     Translation:HumansCells
  18. Halasi M, Schraufnagel DP, Gartel AL. Wild-type p53 protects normal cells against apoptosis induced by thiostrepton. . 2009 Sep 01; 8(17):2850-1. PMID: 19652535.
    Citations: 7     Translation:Humans
  19. Bhat UG, Halasi M, Gartel AL. FoxM1 is a general target for proteasome inhibitors. PLoS One. 2009 Aug 12; 4(8):e6593. PMID: 19672316.
    Citations: 98     Fields:    Translation:HumansCells
  20. Halasi M, Gartel AL. A novel mode of FoxM1 regulation: positive auto-regulatory loop. . 2009 Jun 15; 8(12):1966-7. PMID: 19411834.
    Citations: 65     Translation:HumansCells
  21. Bhat UG, Halasi M, Gartel AL. Thiazole antibiotics target FoxM1 and induce apoptosis in human cancer cells. PLoS One. 2009; 4(5):e5592. PMID: 19440351.
    Citations: 112     Fields:    Translation:HumansCells
  22. Radhakrishnan SK, Halasi M, Bhat UG, Kurmasheva RT, Houghton PJ, Gartel AL. Proapoptotic compound ARC targets Akt and N-myc in neuroblastoma cells. Oncogene. 2008 Jan 24; 27(5):694-9. PMID: 17724478.
    Citations: 9     Fields:    Translation:HumansCells
  23. Radhakrishnan SK, Bhat UG, Halasi M, Gartel AL. P-TEFb inhibitors interfere with activation of p53 by DNA-damaging agents. Oncogene. 2008 Feb 21; 27(9):1306-9. PMID: 17724473.
    Citations: 6     Fields:    Translation:HumansCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact contactcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Halasi's Networks
Click the
buttons for more information and interactive visualizations!
Concepts (135)
Co-Authors (2)
Similar People (60)
Same Department 
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.